3861 results for «2592»

Filter By

3861 results

Transcatheter valve intervention in challenging situations

18 Nov 2019 – From PCR London Valves 2019

Consult this session on transcatheter valve intervention with a selection of studies to discover how to manage challenging situations, such as TAVI in cardiogenic shock, TAVR for failed surgical aortic bioprostheses, and more!

Transcatheter valve intervention in challenging situations

Will PARTNER-3 and Evolut low-risk trials change my practice?

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.

Will PARTNER-3 and Evolut low-risk trials change my practice?

Innovations in transcatheter tricuspid valve intervention

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about the innovations in transcatheter tricuspid valve intervention: discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.

Innovations in transcatheter tricuspid valve intervention

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions

18 Nov 2019 – From PCR London Valves 2019

Consult this session on patient selection for tricuspid valve interventions to gain insights into how clinical and anatomical characteristics influence patient and device selection, and to become more familiar with the key steps in transcatheter tricuspid valve procedures.

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions

Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?

18 Nov 2019 – From PCR London Valves 2019

Consult this session on TAVI vs SAVR in younger lower-risk patients to learn all about the outcomes of various recent trials and how to translate them into your clinical practice, thanks to a selection of challenging cases involving bicuspid aortic valve disease, small aortic annulus, and complex...

Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?

TAVI: novel peri-procedural imaging techniques

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about the novel peri-procedural imaging techniques for TAVI, and discover the impact of initial Evolut TAVR deployment orientation on final valve orientation and coronary re-access, the prognostic value of diastolic flow reversal on clinical outcomes after TAVR, and more!

TAVI: novel peri-procedural imaging techniques

Transcatheter edge-to-edge repair for secondary mitral regurgitation - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from Clinique Pasteur - Toulouse, France

Transcatheter edge-to-edge

TAVI: clinical assessment and early post-procedural discharge

18 Nov 2019 – From PCR London Valves 2019

Consult this session on TAVI to gain insight into various registries and trials regarding clinical assessment and early post-procedural discharge, such as the FIFA-trial, the VICTORY-registry, the FAST TAVI trial, and more!

TAVI: clinical assessment and early post-procedural discharge

Late-Breaking Trials at PCR London Valves 2019 - Session 2

18 Nov 2019 – From PCR London Valves 2019

View this session from PCR London Valves 2019 presenting late-breaking trials on incidence, predictors and outcome of structural valve deterioration in transcatheter vs. SAVR, and percutaneous edge-to-edge repair for tricuspid regurgitation.

Late-Breaking Trials

Mitral and tricuspid transcatheter valves therapies: time to innovate!

Consult this session on mitral and tricuspid transcatheter valves therapies to learn all about the recent innovations and clinical evidences, and discover the Tendyne Clinical Program, a new transcatheter treatment option that eliminates mitral regurgitation.

Mitral and tricuspid transcatheter valves therapies: time to innovate!

Treatment options for valvular and paravalvular mitral regurgitation - Hosted by Italy and Switzerland

18 Nov 2019 – From PCR London Valves 2019

Consult this session to discover various treatment options for valvular and paravalvular mitral regurgitation, with challenging cases such as: percutaneous closure of a paraprosthetic mitral valve leak in a high-risk patient with heart failure and haemolytic anaemia, transcatheter paravalvular leak closure in radiolucent mitral bioprosthesis, SAPIEN 3...

Treatment options for valvular and paravalvular mitral regurgitation - Hosted by Italy and Switzerland

Treatment of aortic stenosis for today - Important considerations for the future

Consult this session to learn more about some important considerations when selecting your TAVI device, how innovations drive improvement in procedural and clinical outcomes, and discover various procedural techniques using the latest generation TAVI system, such as Portico IDE FlexNav, NAVITOR next-gen self-expanding valve, and more!

Treatment of aortic stenosis for today - Important considerations for the future

PCR London Valves 2019 case submissions: Top 3 cases

18 Nov 2019 – From PCR London Valves 2019

Discover three compelling cases on double valve-in-valve, ring fracture and BASILICA, a complex mitral intervention with complications, and the treatment of ascending aorta, aortic root and aortic valve at the same time.

PCR London Valves 2019

Advances in transcatheter mitral and tricuspid repair

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn about the recent advances in transcatheter mitral and tricuspid repair and their impact on your clinical practice, thanks to various registries and studies, such as EREMMI, GRASP-IT, LVEF, CLASP, and more!

Advances in transcatheter mitral and tricuspid repair

Novel transcatheter solutions in unusual clinical scenarios

19 Nov 2019 – From PCR London Valves 2019

Consult this session to discover novel transcatheter solutions in unusual clinical scenarios, with clinical cases such as Inoue balloon for retrograde balloon aortic valvuloplasty, peri-procedural transient ST elevation during LAA closure, and more!

Novel transcatheter solutions in unusual clinical scenarios

Secondary mitral regurgitation in 2019: mastering the full spectrum of treatment options

19 Nov 2019 – From PCR London Valves 2019

Consult this session on secondary mitral regurgitation to update your knowledge regarding the contemporary evidence base for its management, and learn more about the complexity and variability of clinical presentation and the spectrum of therapeutic options, thanks to a selection of studies and clinical cases.

Secondary mitral regurgitation in 2019: mastering the full spectrum of treatment options

Complications of surgical and transcatheter valve interventions: the case that taught me most

19 Nov 2019 – From PCR London Valves 2019

Consult this session on the complications of surgical and transcatheter valve interventions to learn tips and tricks from high-volume experienced operators, and to discover techniques for an effective prevention and management of life-threatening complications.

Complications of surgical and transcatheter valve interventions: the case that taught me most

Coronary lithotripsy in complex calcified lesions

21 May 2019 – From EuroPCR 2019

Consult this session on coronary lithotripsy, and discover how this novel procedure may facilitate the treatment of complex calcified lesions, such as undilatable stenosis, refractory in-stent restenotic lesions, and more!

Coronary lithotripsy in complex calcified lesions

Optimising the generation and regulatory application of clinical evidence in the European Union and the United States

22 May 2019 – From EuroPCR 2019

Consult this session to discover innovative approaches for collecting and utilising clinical evidence, and learn more about how to conduct efficient clinical research to support marketing approval in the European Union, the United States, or regions dependent on the CE mark or FDA approval.

Optimising the generation and regulatory application of clinical evidence in the European Union and the United States

How to choose material for a successful superficial femoral artery popliteal angioplasty?

22 May 2019 – From EuroPCR 2019

Consult this session to learn all about lesion specific strategies in complex superficial femoral artery obstructive disease, the impact of lesion length and calcification on treatment choice, and how to define treatment algorithm for drug coated balloons and stent devices.

How to choose material
Didn’t find what you were looking for?